Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Title:
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Author:
Chanan-Khan, Asher Cramer, Paula Demirkan, Fatih Fraser, Graeme Silva, Rodrigo Santucci Grosicki, Sebastian Pristupa, Aleksander Janssens, Ann Mayer, Jiri Bartlett, Nancy L Dilhuydy, Marie-Sarah Pylypenko, Halyna Loscertales, Javier Avigdor, Abraham Rule, Simon Villa, Diego Samoilova, Olga Panagiotidis, Panagiots Goy, Andre Mato, Anthony Pavlovsky, Miguel A Karlsson, Claes Mahler, Michelle Salman, Mariya Sun, Steven Phelps, Charles Balasubramanian, Sriram Howes, Angela Hallek, Michael